Bayer joins Russian firm to manufacture drugs

German pharmaceutical company Bayer and Yunona Holdings, representing the Ural Pharmaceutical Cluster (UPC) of Russia have entered a memorandum of understanding to manufacture drugs in Russia. The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported.The UPC which is a complex of interconnected production and infrastructure facilities is known to manufacture and sell medicines and medical equipment.The cluster has received funds worth 27.3 bn roubles (around $860m) from Russia’s economic development programme between 2010 and 2015.